MX383746B - Solución de isoxazolina que contiene vitamina e para usarse con agua potable desinfectada. - Google Patents
Solución de isoxazolina que contiene vitamina e para usarse con agua potable desinfectada.Info
- Publication number
- MX383746B MX383746B MX2017016671A MX2017016671A MX383746B MX 383746 B MX383746 B MX 383746B MX 2017016671 A MX2017016671 A MX 2017016671A MX 2017016671 A MX2017016671 A MX 2017016671A MX 383746 B MX383746 B MX 383746B
- Authority
- MX
- Mexico
- Prior art keywords
- drinking water
- isoxazoline
- solution containing
- vitamin
- containing vitamin
- Prior art date
Links
- WEQPBCSPRXFQQS-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazole Chemical compound C1CC=NO1 WEQPBCSPRXFQQS-UHFFFAOYSA-N 0.000 title abstract 5
- 239000003651 drinking water Substances 0.000 title abstract 5
- 235000020188 drinking water Nutrition 0.000 title abstract 5
- 229940088594 vitamin Drugs 0.000 title 1
- 229930003231 vitamin Natural products 0.000 title 1
- 235000013343 vitamin Nutrition 0.000 title 1
- 239000011782 vitamin Substances 0.000 title 1
- 150000003722 vitamin derivatives Chemical class 0.000 title 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 4
- 241001465754 Metazoa Species 0.000 abstract 3
- 206010061217 Infestation Diseases 0.000 abstract 2
- 229930003427 Vitamin E Natural products 0.000 abstract 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 abstract 2
- 244000045947 parasite Species 0.000 abstract 2
- 238000011012 sanitization Methods 0.000 abstract 2
- 229940046009 vitamin E Drugs 0.000 abstract 2
- 235000019165 vitamin E Nutrition 0.000 abstract 2
- 239000011709 vitamin E Substances 0.000 abstract 2
- 230000002141 anti-parasite Effects 0.000 abstract 1
- 239000003096 antiparasitic agent Substances 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 239000006184 cosolvent Substances 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Fodder In General (AREA)
- Mechanical Engineering (AREA)
- Ceramic Engineering (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Pathology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15173454 | 2015-06-23 | ||
| PCT/EP2016/064449 WO2016207234A1 (en) | 2015-06-23 | 2016-06-22 | Isoxazoline solution containing vitamin e for use with sanitized drinking water |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017016671A MX2017016671A (es) | 2018-03-15 |
| MX383746B true MX383746B (es) | 2025-03-14 |
Family
ID=53488226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017016671A MX383746B (es) | 2015-06-23 | 2016-06-22 | Solución de isoxazolina que contiene vitamina e para usarse con agua potable desinfectada. |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20180169073A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3313400B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6933983B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN107750159B (cg-RX-API-DMAC7.html) |
| BR (1) | BR112017027855B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2920394T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE059228T2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX383746B (cg-RX-API-DMAC7.html) |
| PL (1) | PL3313400T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016207234A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170232024A1 (en) | 2014-08-04 | 2017-08-17 | Jerry Tan Eye Surgery Pte Ltd | Pharmaceutical compositions for demodex related blepharitis and eyelid crusting |
| KR102668200B1 (ko) * | 2015-10-28 | 2024-05-23 | 주식회사유한양행 | 지속형 fgf21 융합 단백질 및 이를 포함하는 약학적 조성물 |
| UY37137A (es) | 2016-02-24 | 2017-09-29 | Merial Inc | Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos |
| CN111655241B (zh) | 2017-12-15 | 2024-10-15 | 塔苏斯制药有限公司 | 用于治疗睑炎的异恶唑啉驱虫剂制剂和方法 |
| US12502377B2 (en) | 2019-04-04 | 2025-12-23 | Tarsus Pharmaceuticals, Inc. | Method of eradicating ticks that attach to humans using lotilaner formulations |
| MX2022007455A (es) | 2019-12-18 | 2022-08-15 | Elanco Tiergesundheit Ag | Derivados de isoxazolina como plaguicidas. |
| EP4185585A1 (en) | 2020-07-24 | 2023-05-31 | Elanco Us Inc. | Process for making an isoxazoline compound and intermediate thereof |
| CN114306231B (zh) * | 2021-12-29 | 2023-03-24 | 天津市中升挑战生物科技有限公司 | 一种氟雷拉纳杀虫剂及其制备方法和应用 |
| CN115266988A (zh) * | 2022-08-01 | 2022-11-01 | 江苏慧聚药业股份有限公司 | 一种氟雷拉钠有关物质的检测方法 |
| CN117064851A (zh) * | 2023-09-20 | 2023-11-17 | 中国农业大学 | 一种异噁唑啉类驱虫药制剂的制备方法 |
| CN118477040B (zh) * | 2024-04-11 | 2025-02-25 | 河北威远药业有限公司 | 一种氟雷拉纳溶液的制备方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5962488A (en) * | 1998-04-08 | 1999-10-05 | Roberts Laboratories, Inc. | Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives |
| IL153120A0 (en) | 2000-06-27 | 2003-06-24 | Procter & Gamble | Water treatment compositions |
| US20050005868A1 (en) * | 2003-07-11 | 2005-01-13 | Shepard Allan T. | Animal drinking water production |
| CN102558082B (zh) | 2004-03-05 | 2015-09-30 | 日产化学工业株式会社 | 异噁唑啉取代苯甲酰胺化合物的制备中间体 |
| TWI412322B (zh) | 2005-12-30 | 2013-10-21 | Du Pont | 控制無脊椎害蟲之異唑啉 |
| JP2007319124A (ja) * | 2006-06-02 | 2007-12-13 | Nippon Tablet Kk | 健康食品 |
| AU2008235089B8 (en) | 2007-04-10 | 2014-04-10 | Bayer Intellectual Property Gmbh | Insecticidal aryl isoxazoline derivatives |
| TWI430995B (zh) | 2007-06-26 | 2014-03-21 | Du Pont | 萘異唑啉無脊椎有害動物控制劑 |
| CA2971008A1 (en) | 2007-06-27 | 2008-12-31 | E. I. Du Pont De Nemours And Company | Animal pest control method |
| US20090024541A1 (en) * | 2007-07-20 | 2009-01-22 | Gary Kremen | Power purchase methods, agreements and financial instruments for tax-advantaged financing residential renewable energy equipment |
| TWI556741B (zh) * | 2007-08-17 | 2016-11-11 | 英特威特國際股份有限公司 | 異唑啉組成物及其作為抗寄生蟲藥上的應用 |
| TWI411395B (zh) | 2007-12-24 | 2013-10-11 | Syngenta Participations Ag | 殺蟲化合物 |
| CN102088856B (zh) * | 2008-07-09 | 2015-11-25 | 巴斯夫欧洲公司 | 包含异*唑啉化合物的杀虫活性混合物i |
| US7951404B2 (en) | 2008-07-11 | 2011-05-31 | Sanosil Ag | Concentrate for preparing a disinfectant and methods for its preparation and use |
| CA2747060A1 (en) | 2008-12-18 | 2010-07-15 | Novartis Ag | Isoxazolines derivatives and their use as pesticide |
| AR074790A1 (es) | 2008-12-19 | 2011-02-09 | Novartis Ag | Derivados de isooxazol sustituidos, composiciones farmaceuticas y para el control de parasitos que los comprenden y su uso en metodos para controlar parasitos en y sobre animales de sangre caliente. |
| PL3560923T3 (pl) | 2009-12-17 | 2021-12-27 | Boehringer Ingelheim Animal Health USA Inc. | Dihydroazolowe kompozycje przeciwpasożytnicze i kompozycje je zawierające |
| WO2011092287A1 (en) | 2010-02-01 | 2011-08-04 | Basf Se | Substituted ketonic isoxazoline compounds and derivatives for combating animal pests |
| WO2011124998A1 (en) | 2010-04-08 | 2011-10-13 | Pfizer Inc. | Substituted 3,5- di phenyl - isoxazoline derivatives as insecticides and acaricides |
| WO2012155352A1 (en) | 2011-05-19 | 2012-11-22 | Eli Lilly And Company | Dihydroisoxazole compounds, parasiticidal uses and formulations thereof |
| WO2013026695A1 (en) | 2011-08-25 | 2013-02-28 | Syngenta Participations Ag | Isoxazoline derivatives as insecticidal compounds |
| WO2013026931A1 (en) | 2011-08-25 | 2013-02-28 | Syngenta Participations Ag | Isoxazoline derivatives as insecticidal compounds |
| SG11201400558YA (en) * | 2011-09-12 | 2014-04-28 | Merial Ltd | Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof |
| CA2924537C (en) | 2013-09-30 | 2018-01-16 | Todd P. Foster | Long-acting spiro-isoxazoline formulations |
| US9371293B2 (en) | 2013-10-25 | 2016-06-21 | Sumitomo Chemical Company, Limited | Isoxazoline compound composition |
| ES2905848T3 (es) | 2013-11-01 | 2022-04-12 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos de isoxazolina antiparasitarios y plaguicidas |
| EP3079474B1 (en) * | 2013-12-10 | 2019-07-03 | Intervet International B.V. | Antiparasitic use of isoxazoline compounds |
| CN110327468B (zh) * | 2013-12-20 | 2023-04-28 | 英特维特国际股份有限公司 | 异噁唑啉组合物及其在预防或治疗动物的寄生虫侵袭中的用途 |
| US10272071B2 (en) * | 2013-12-20 | 2019-04-30 | Intervet Inc. | Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultry |
| MX2017005721A (es) * | 2014-11-03 | 2017-07-28 | Zoetis Services Llc | Composicion veterinaria masticable agradable al paladar. |
-
2016
- 2016-06-22 CN CN201680036814.8A patent/CN107750159B/zh active Active
- 2016-06-22 WO PCT/EP2016/064449 patent/WO2016207234A1/en not_active Ceased
- 2016-06-22 BR BR112017027855-3A patent/BR112017027855B1/pt active IP Right Grant
- 2016-06-22 JP JP2017566402A patent/JP6933983B2/ja active Active
- 2016-06-22 ES ES16733385T patent/ES2920394T3/es active Active
- 2016-06-22 HU HUE16733385A patent/HUE059228T2/hu unknown
- 2016-06-22 US US15/735,252 patent/US20180169073A1/en not_active Abandoned
- 2016-06-22 PL PL16733385.5T patent/PL3313400T3/pl unknown
- 2016-06-22 EP EP16733385.5A patent/EP3313400B1/en active Active
- 2016-06-22 MX MX2017016671A patent/MX383746B/es unknown
-
2019
- 2019-07-26 US US16/523,780 patent/US11179372B2/en active Active
-
2021
- 2021-07-30 US US17/390,258 patent/US11878006B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BR112017027855B1 (pt) | 2022-11-16 |
| BR112017027855A2 (cg-RX-API-DMAC7.html) | 2018-08-21 |
| US20180169073A1 (en) | 2018-06-21 |
| US11179372B2 (en) | 2021-11-23 |
| JP6933983B2 (ja) | 2021-09-08 |
| EP3313400B1 (en) | 2022-06-15 |
| CN107750159A (zh) | 2018-03-02 |
| PL3313400T3 (pl) | 2022-07-25 |
| ES2920394T3 (es) | 2022-08-03 |
| JP2018521995A (ja) | 2018-08-09 |
| MX2017016671A (es) | 2018-03-15 |
| WO2016207234A1 (en) | 2016-12-29 |
| EP3313400A1 (en) | 2018-05-02 |
| US20210354283A1 (en) | 2021-11-18 |
| US20190343808A1 (en) | 2019-11-14 |
| CN107750159B (zh) | 2021-10-29 |
| HUE059228T2 (hu) | 2022-10-28 |
| US11878006B2 (en) | 2024-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX383746B (es) | Solución de isoxazolina que contiene vitamina e para usarse con agua potable desinfectada. | |
| MX2016008118A (es) | Composiciones de isoxazolina y uso de las mismas en la prevencion o tratamiento de infestaciones parasitarias en animales. | |
| MX373444B (es) | Compuestos organicos de monobactam para el tratamiento de infecciones bacterianas. | |
| MD4577B1 (ro) | Compoziţii masticabile de uz veterinar care conţin agent activ izoxazolinic şi utilizarea acestora în tratamentul sau prevenirea unei infestări sau infecţii parazitare | |
| CL2017002536A1 (es) | Formulaciones inyectables de liberación extendida que comprenden un agente activo de isoxazolina, métodos y usos de las mismas. | |
| MX2017010740A (es) | Formulaciones inyectables de larga duracion que comprenden un agente activo de isoxazolina, metodos y usos de las mismas. | |
| MX376210B (es) | Uso de derivados de isoxazolina para el tratamiento o prevención de infestaciones por artrópodos en aves de corral. | |
| CL2015002744A1 (es) | Alimento para peces que comprende azadiractina, útil para el tratamiento y/o prevención de infecciones y/o infestaciones parasitarias, particularmente contra el piojo de mar lepeophtherius salmonis. | |
| MX2017003205A (es) | Composiciones antimicrobianas y sus metodos de uso. | |
| CL2015002319A1 (es) | Dispositivo y sistema para el tratamiento de peces. | |
| CL2017001025A1 (es) | Compuestos para usarse en el tratamiento antihelmíntico | |
| CL2017000178A1 (es) | Compuestos para usar en el tratamiento antihelmíntico | |
| EP3732968A4 (en) | Antimicrobial agent containing hypochlorous acid | |
| MX2017002818A (es) | Composiciones topicas de pterostilbeno para utilizarse en el tratamiento de la perdida inducida por uv de la funcion de barrera en la piel. | |
| MX2017004899A (es) | Compuestos derivado de pirazolina y su uso en una pauta posológica semanal contra la inflamación y el dolor derivados de la enfermedad articular degenerativa en mamíferos. | |
| UY36389A (es) | Composiciones y usos de las mismas para el tratamiento de ulceras y sintomas relacionados en animales no humanos | |
| MX2016011572A (es) | Composiciones antimicrobianas de acido organico. | |
| MX380385B (es) | Agente para el tratamiento de infeccion respiratoria. | |
| CL2018002422A1 (es) | Preparación que contiene agua de mar a la que se ha agregado un compuesto de potasio. | |
| FR3019047B1 (fr) | Diffuseur d'agent parfumant et/ou assainissant active par retournement. | |
| CL2012002768A1 (es) | Solucion antiseptica para prevencion de mastitis subclinica en vacas lecheras que comprende una mezcla de propoleo y solucion de miel de abejas en proporciones desde 1:5 a 5:1, uso de la solucion antiseptica porque sirve para la profilaxis, prevencion y control de mastitis subclinica de vacas lecheras. | |
| ES2388268B1 (es) | Comprimidos para el tratamiento y desinfeccion de aguas que contienen un derivado halogenado y un lubricante | |
| MX2019012608A (es) | Composiciones antimicrobianas con agentes efervescentes. | |
| CL2016003271A1 (es) | Métodos para tratar infecciones | |
| AR109209A1 (es) | Composición farmacéutica para prevención o tratamiento de enfermedades neurodegenerativas |